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Background: The American short form Patient Activation Measure (PAM) is a 13-item instrument which assesses
patient (or consumer) self-reported knowledge, skills and confidence for self-management of one’s health or
chronic condition. In this study the PAM was translated into a Dutch version; psychometric properties of the Dutch
version were established and the instrument was validated in a panel of chronically ill patients.
Methods: The translation was done according to WHO guidelines. The PAM 13-Dutch was sent to 4178 members
of the Dutch National Panel of people with Chronic illness or Disability (NPCD) in April 2010 (study A) and again to
a sub sample of this group (N= 973) in June 2010 (study B). Internal consistency, test-retest reliability and
cross-validation with the SBSQ-D (a measure for Health literacy) were computed. The Dutch results were compared
to similar Danish and American data.
Results: The psychometric properties of the PAM 13-Dutch were generally good. The level of internal consistency is
good (α= 0.88) and item-rest correlations are moderate to strong. The Dutch mean PAM score (61.3) is comparable
to the American (61.9) and lower than the Danish (64.2). The test-retest reliability was moderate. The association
with Health literacy was weak to moderate.
Conclusions: The PAM-13 Dutch is a reliable instrument to measure patient activation. More research is needed
into the validity of the Patient Activation Measure, especially with respect to a more comprehensive measure of
Health literacy.Background
In 2004 Hibbard et al. developed and tested the Patient
Activation Measure (PAM), a 22-item instrument which
assesses patient (or consumer) self-reported knowledge,
skills and confidence for self-management of one’s
health or chronic condition [1]. In 2005 a 13-item Short
Form of the PAM was developed, which has the same
psychometric properties as the longer version and is
both reliable and valid – see Table 1 [2]. Both versions
of the instrument measure the level of activation of a
specific individual. The PAM divides consumers and
patients into one of four progressively higher activation
levels, which are associated with specific self-care and
other health related behaviours. Research has repeatedly* Correspondence: j.rademakers@nivel.nl
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distribution, and reproduction in any mediumshown that a higher score on the PAM is positively asso-
ciated with various health related behaviours, such as
preventive care and lifestyle behaviours, information
seeking and use of health information, health outcomes
and healthcare use, monitoring and medication adher-
ence, conduct in the patient-provider encounter and
self-management [3,4]. These effects have been demon-
strated both in a clinical setting with chronically ill
patients but also in other populations (e.g. company
employees, senior citizens in community centres) [5,6].
Though the concept of patient activation has a high
face validity and was carefully constructed using experts
consensus and patient focus groups [1], an important
question remains what construct the instrument is actu-
ally measuring. Studies on the construct validity of the
PAM predominantly focus on the possible overlap with
the concept of health literacy. In some studies the rela-
tive contribution of health literacy and patient activationntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 13 item Patient Activation Measure1
1 When all is said and done, I am the person who is responsible for managing my health condition
2 Taking an active role in my own health care is the most important factor in determining my health and ability to function
3 I am confident that I can take actions that will help prevent or minimize some symptoms or problems associated with my health condition
4 I know what each of my prescribed medications do
5 I am confident that I can tell when I need to go get medical care and when I can handle a health problem myself
6 I am confident I can tell my health care provider concerns I have even when he or she does not ask
7 I am confident that I can follow through on medical treatments I need to do at home
8 I understand the nature and causes of my health condition(s)
9 I know the different medical treatment options available for my health condition
10 I have been able to maintain the lifestyle changes for my health that I have made
11 I know how to prevent further problems with my health condition
12 I am confident I can figure out solutions when new situations or problems arise with my health condition
13 I am confident that I can maintain lifestyle changes like diet and exercise even during times of stress
1 Original version [2].
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behaviours and choices [7-9]. Two studies showed that
the association between patient activation and measures
of health literacy was weak, indicating that these are two
distinct concepts [7,8]. The other study distinguished be-
tween numeracy, literacy and activation [9]. In this study
more activated patients were better able to understand
and use comparative health care information, even when
they had lower numeracy and literacy skill levels. It was
suggested that activation might be a proxy for motiv-
ation and can compensate for lower skills. In all three
studies, however, health literacy was defined on a func-
tional level. The broader definition of health literacy by
Nutbeam [10] distinguishes between functional, commu-
nicative/interactive and critical literacy. These latter
components definitely show conceptual overlap with pa-
tient activation. Nutbeam includes aspects such as mo-
tivation, personal skills and self-efficacy in his definition
of health literacy and acknowledges that ‘different levels
of literacy progressively allow for greater autonomy and
personal empowerment’ [10].
Knowing a person’s activation level is relevant because
it can help providers to effectively communicate with
their patients and to tailor health messages and self-
management goals [4]. Compared to the regular patient
approach, an intervention with tailored messages has
proven to lead to greater improvement in the patients’
biometrical clinical indicators, in their adherence to pre-
scribed medication regimens and to a reduction in hos-
pitalizations and use of the emergency department [11].
Furthermore, patient activation has proven to be a
changeable characteristic [6,12]. This makes the concept
even more relevant since it can not only be used for cat-
egorizing patients and consumers and tailoring support
and education, but also for actual improvement of con-
sumer participation with respect to health and health
care, both on an individual and on a population level.The Patient Activation Measure has been studied ex-
tensively in the USA. Since many of the American pro-
blems regarding the management of health and chronic
diseases also exist in the Netherlands, there is a definite
clinical and scientific need for an instrument that can
help differentiate patients and consumers into subgroups
that require different strategies in health support, infor-
mation and communication. An official, validated Dutch
version of the PAM would be suitable and relevant for
this purpose. Similar initiatives have been taken in
Norway and Denmark [13,14]. Therefore, a research
project was performed in the Netherlands in order to:
▪ translate the American short form Patient Activation
Measure (PAM 13) into a Dutch version;
▪ establish the psychometric properties of the Dutch
version of the PAM 13; and
▪ validate the Dutch version of the PAM in a panel of
chronically ill patients.
For validation purposes, the concept of health literacy
was chosen, even though previous studies have shown a
weak association between the two [7-9]. Since all these
studies were done in the USA, and the Netherlands’
health care system and patients are different to a major
extent, the choice for replication was made. Only very
recently, health literacy instruments were translated in
Dutch [15] and available for clinical practice and re-
search. Therefore this is the first opportunity to confirm
or reject earlier findings on the relationship between pa-
tient activation and health literacy in the Dutch context.
Methods
Translation and adaptation process
For the translation and adaptation of the PAM 13, a sys-
tematic approach conform instructions of the WHO was
followed [16]. This method includes the following steps:
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translation, pre-testing/cognitive interviewing and con-
sensus about the final version. Two independent Dutch
translators performed the forward translation. The ex-
pert panel included both translators and three research-
ers with an expertise in chronic care, diversity in patient
groups and measurement development. Discrepancies
between the two translations were discussed and
resolved. At the end of the expert meeting a single trans-
lation of the PAM 13 was agreed upon. This instrument
was then translated back into English. There were only a
few minor textual discrepancies between the backward
translation and the original instrument, which led to the
conclusion that the Dutch translation was satisfactory
and ready for pre-testing.
Pre-testing was done in a focus group and 11 individ-
ual cognitive interviews. A sample of 185 former partici-
pants of the Dutch National Panel of people with
Chronic illness or Disability (NPCD) were asked to par-
ticipate in the pre-test. Five agreed to take part in the
focus group (3 male, 2 female, mean age 64), whereas 11
preferred an interview (5 male, 6 female, mean age 65).
Former participants were chosen because a sample from
the current members of the Panel would be drawn for
the main study (see under participants). In both the
focus group and the interviews, respondents filled out
the instrument at the beginning of the session. Then, the
moderator (JR) or interviewer (JN) would ask questions
about the general comprehensiveness of the instrument.
Subsequently, each of the 13 items of the PAM was dis-
cussed. Respondents were asked to think out loud, con-
templating about their interpretation and the possible
meaning and phrasing of the item. Also the answering
categories were discussed. The focus group and cogni-
tive interviews didn’t lead to major alterations in the
Dutch translation of the PAM 13, though some items
were slightly rephrased. The final version of the
instrument (PAM 13-Dutch) is attached as an Additional
file 1 to this paper (copyright Insignia Health www.
InsigniaHealth.com).
Participants
The PAM 13-Dutch was sent to 2542 members of the
Dutch National Panel of people with Chronic illness or
Disability (NPCD) in April 2010 (study A) and again to
973 members in June 2010 (study B). The second sample
were patients with Asthma and/or COPD, who had also
received a questionnaire in study A. By doing so, the
test-retest reliability of the instrument could be
established.
The Dutch National Panel of people with Chronic ill-
ness or Disability (NPCD) is a nationwide prospective
panel-study in the Netherlands. NPCD consists of over
4000 people aged 15 years and over with medicallydiagnosed chronic disease(s) and/or moderate to severe
levels of physical disability. It has been set up to provide
information with respect to the consequences of chronic
illness and disability from the patient’s perspective. For
the purpose of this study, we only selected panel mem-
bers who had been diagnosed with a somatic chronic
disease. Patients are included in the panel on the basis
of a the oldest medical diagnosis of a chronic disease
(=index disease). The medical diagnosis or diagnoses of
chronic diseases of the patients were registered by their
general practitioner (GP) using the International Classi-
fication of Primary Care (ICPC). The registered chronic
disease (oldest diagnosis = index disease) of the partici-
pants in study A could be classified into nine broad cat-
egories: asthma and COPD (together 38%), diabetes
(12%), cardiovascular diseases (11%), rheumatic diseases
(11%), neurological diseases (6%), cancer (4%), chronic
digestive diseases (4%) en other chronic diseases (15%).
Asthma and COPD patients were oversampled in study
A because they would be approached again for study B.
We had chosen to validate the PAM 13-Dutch in the
NPCD subsample of people with a chronic illness be-
cause it closely resembled the samples which were used
in the validation studies in the United States and
Denmark [2,14]. In the USA, a group of 1515 randomly
selected adults (age 45+) participated in the development
study, of which 79% had at least one chronic disease [2]. In
the Danish study, 467 patients (age 43 - 75 years) who were
diagnosed with different aspects of dysglycaemia (Impaired
Fasting Glucose, Impaired Glucose Tolerance and Type 2
diabetes) participated [14].
In both data collections, the instrument was part of a
larger survey on chronic care and self-management.
When entering the Panel, the participants give informed
consent to the use of their data for research purposes.
According to Dutch law, no further ethical approval is
required.
Measures
Age, gender, education level and self-reported health
were measured as background variables. Education in
the Netherlands was divided in three groups; low (no,
primary school, or vocational training), middle (second-
ary or vocational education) or high (professional higher
education or university). Self-reported health is the first
item of the SF 36 (http://www.sf-36.org).
Patient activation was measured using the PAM 13-
Dutch, which consists of 13 items. The answering cat-
egories per item are 4-point Likert scales, ranging from
totally disagree to totally agree and ‘non applicable’. The
design of the instrument reflects the four stages of acti-
vation in a progressing difficulty of the items: level 1
(patients believe that their role is important; items 1 and
2), level 2 (patients have confidence and knowledge to
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and level 4 (staying on course under stress; items 12 and
13) [2].
To establish the level of Health Literacy, we used the
Dutch translation of the Set of Brief Screening Questions
(SBSQ-D) and followed the corresponding scoring
instructions [15]. This is a self report instrument which
consists of three items and focuses on the ability to read
and understand medical information. The Dutch version
of the Set of Brief Screening Questions (SBSQ-D) of
functional health literacy included: 1) “How often do
you have someone help you read materials?”, 2) “How
confident are you filling out medical forms by yourself?”
and 3) “How often do you have problems learning about
your medical condition because of difficulty understand-
ing written information?” Question 1) and 3) had re-
sponse options never, occasionally, sometimes, often or
always, whereas for question 2) they were extremely,
quite a bit, somewhat, a little bit and not at all. Answers
were scored on a Likert scale from 1 to 4 where 1 was
assigned to never or extremely, and 4 to merged
responses often/always and a little bit/not at all. Cron-
bach’s α for the SBSQ-D was 0.73, indicating acceptable
internal consistency.
Statistical analyses
The analyses were performed on the data of study A, ex-
cept for the test-retest reliability where the datasets from
study A and B were combined. For comparability with
the Dutch and American studies, we focused in our ana-
lyses on the subsample in study A of people with a
chronic illness.
To establish the psychometric properties of the PAM
13-Dutch the data quality and internal consistency of
the instrument were assessed. For data quality, we
looked at the mean (with standard deviation), median,
percentage of missing data, and percentage of ‘non ap-
plicable’ answers. Internal consistency was measured as
the Cronbach’s α, inter-item and item-rest correlations
(Pearson’s r). Item-rest correlations are the correlations
between an item and the scale that is formed by all other
items. Since very strong correlations are rare in the so-
cial sciences, in our study a correlation ≥ 0.50 is consid-
ered strong, r ≥ 0.30 moderate and r ≥ 0.10 weak [17].
Furthermore, the distribution of levels of activation and
adjusted mean overall scores in the Dutch sample were
described (by gender, age, educational level and self-
reported health) and the latter were compared to the
Danish and American scores.
To validate the PAM 13-Dutch, the test-retest reliabil-
ity as an indicator of stability and construct validity was
established. We also looked at associations between the





In study A 2542 questionnaires were sent of which 2070
were completed and returned. The gross response was
therefore 2070/2542*100 = 81.4%. Of this sample, the
data of 233 respondents were excluded: 198 because
they had filled out less than 7 items on the PAM-Dutch
questionnaire and 35 because they had responded to all
the items with totally agree or disagree. These are
requirements to be able to be able to compute a valid
PAM-score. The net response rate in study A was there-
fore 1837/2542*100 = 72.3%. The mean age of these par-
ticipants was 58.7 years (SD 0.38) (age 15 - 93 years). Of
the sample, 56.2% was female. Asthma, COPD and dia-
betes were the most frequent reported chronic illnesses
with a prevalence in the sample of respectively 20.3, 13.5
and 11.5 percent.
Study B
In study B 973 questionnaires were sent to patients with
Asthma and/or COPD, who had also participated in
study A. Of these questionnaires 705 were completed
and returned (gross response: 705/973*100 = 72.5%). Of
these, 33 respondents were excluded because they had
filled out less than 7 items on the PAM-Dutch question-
naire and 26 because they had responded to all the items
with totally agree or disagree. The net response for study
B was: 672/973*100 = 69.1%. The mean age of these par-
ticipants was: 58.7 years (SD 0.58) and 55.4% was female.
The time between data collection of study A en B was
approximately 8 to 12 weeks.
Of the remaining 672 respondents in study B, the data
of 499 could be used for the test-retest analysis. The
other 173 respondents had been excluded in study A be-
cause they had not filled out the PAM according to the
requirements.
Psychometric properties
To establish the psychometric properties of the PAM
13-Dutch the data quality, internal consistency and
item-rest correlations were assessed (Table 2).
With respect to data quality, we looked at the mean
(with standard deviation), median, percentage of missing
data, and percentage of ‘non applicable’ answers. Over-
all, the mean scores on the items varied between 2.62
and 3.32. In general, the last items have a lower mean
score compared to the earlier items in the questionnaire.
However, in our results the individual item sequence did
not exactly follow the original US scale (from higher to
lower scoring items).
Table 2 Data quality and item-rest correlations of the










1 1788 3.32 0.71 3 1.0 1.7 0.49
2 1542 3.20 0.69 3 3.3 12.8 0.50
3 1716 3.10 0.73 3 1.5 5.1 0.60
4 1736 3.20 0.66 3 0.4 5.1 0.54
5 1815 3.24 0.60 3 0.5 0.7 0.62
6 1805 3.29 0.61 3 0.9 0.9 0.55
7 1487 3.30 0.57 3 1.6 17.5 0.62
8 1771 3.23 0.67 3 0.9 2.7 0.66
9 1733 3.10 0.67 3 1.4 4.3 0.64
10 1565 3.04 0.66 3 1.7 13.1 0.51
11 1694 2.96 0.70 3 1.0 6.8 0.61
12 1667 2.62 0.75 3 1.1 8.1 0.50
13 1678 2.84 0.70 3 1.0 7.6 0.46
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reported (between 0.4% and 3.3%). Three items (7, 10
and 2) are scored as ‘not applicable’ by more than 10%
of the participants. For item 7 (‘I am confident that I can
follow through on medical treatments I need to do at
home’) and item 10 (‘I have been able to maintain the
lifestyle changes for my health that I have made’) this
may actually be the correct answer. Item 2 (‘Taking an
active role in my own health care is the most important
factor in determining my health and ability to function’)
requires rephrasing in the Dutch version: it has the high-
est percentage (3.3%) of missing values and furthermore
12.8% scored the item as not applicable, which is in-
appropriate since it is a general statement which applies
to all participants.
Internal consistency was measured as the Cronbach’s α
and inter-item correlations. Cronbach’s α for the sum
scale was 0.88, which is similar to the Danish version
(0.89) and is considered as a good level of internal
consistency. The inter-item correlations ranged from
0.14-0.63. Item-rest correlations per item to the sum
scale were moderate (for item 1 and 13) to strong (for
all other items) and varied between 0.46 and 0.66.
The distribution of levels of activation and adjusted
mean overall scores in the Dutch sample were described
by gender, age, educational level and self-reported
health. These data were compared to the Danish and
American scores (Table 3). In the Dutch sample, there is
a clear association between gender, age, educational
level, self-reported health and patient activation score. In
general male, younger, higher educated and healthier
participants have higher scores on the PAM 13-Dutch.
Self-reported health is the most distinguishing variable
in this respect: whereas almost two thirds (64.6%) of thepersons who report poor health have activation level 1
or 2, most people who report to be in good or very good
health have activation level 3 or 4.
Comparing the Dutch results to the Danish and Ameri-
can data, we see that the Dutch mean PAM score (61.3) is
comparable to the American (61.9) but somewhat lower
than the Danish (64.2). While in the other countries
women score higher on the PAM-13 than men, in the
Netherlands the opposite is true. Associations with age,
educational level and self-reported health in the three
countries are similar. Also in Denmark and the USA, the
association with self-reported health is strongest.
Validation
To validate the PAM 13-Dutch, the test-retest reliability
was established (Table 4). On item level, the correlations
between the first and the second measurement varied
between 0.25 and 0.49 (p< .001), and was moderate on
average. For the scale as a whole, the correlation was
0.47 (p< .001).
To establish construct validity, correlations between
the PAM scores and the SBSQ-D as a measure of Health
literacy were computed. In our sample 23 respondents
scored low on Health literacy (score of 2 or less on the
SBSQ-D [15]), their mean PAM score was 48.6. Most
participants (N = 1814) scored adequate on the SBSQ-D
(score higher than 2). Their mean PAM score was much
higher (61.4) compared to the low literacy group, indi-
cating that as health literacy increases the activation
level of patients generally goes up. The overall correl-
ation between the SBSQ-D and PAM scores however
was weak to moderate (r = 0.28).
Discussion
The PAM-13 Dutch is a reliable instrument to measure
patient activation. The level of internal consistency is
good (α= 0.88) and item-rest correlations are moderate
to strong. Compared to the Danish data, the internal
consistency as measured by Cronbach’s α is comparable
in the Dutch sample. Unfortunately, there is no α pub-
lished for the American sample. Internal consistency
might further be improved by rephrasing item 2 (‘Taking
an active role in my own health care is the most import-
ant factor in determining my health and ability to func-
tion’) which has the highest percentage of missing
values, a high and inappropriate level of ‘non applicable’
scores and a relatively low item-rest correlation. Though
the individual item sequence in our study did not exactly
follow the original US scale, in general the progressing
difficulty of the items is reflected in the mean scores.
Further validation in other Dutch samples and more
specific statistical (Rasch) analyses will have to confirm
whether the sequence of the original US scale will re-
quire readjustment in the Netherlands.
Table 4 Test - retest reliability of the PAM between study
A and study B







1 475 3.31 3.30 0.35 <0.001
2 357 3.23 3.17 0.25 <0.001
3 448 3.12 3.09 0.31 <0.001
4 471 3.24 3.22 0.36 <0.001
5 490 3.22 3.25 0.32 <0.001
6 484 3.30 3.33 0.42 <0.001
7 393 3.36 3.43 0.41 <0.001
8 482 3.33 3.31 0.32 <0.001
9 467 3.11 3.03 0.42 <0.001
10 383 3.04 2.94 0.44 <0.001
11 448 2.98 2.90 0.40 <0.001
12 415 2.62 2.59 0.47 <0.001
13 427 2.83 2.83 0.49 <0.001
Total score 499 61.94 60.48 0.47 <0.001
Table 3 Reliability of the Dutch 13-item PAM compared to the Danish and American version




Level 1 Level 2 Level 3 Level 4 Overall Overall Overall
Sample (N) 314 359 590 574 1837 344 454
Mean activation score 41.1 50.3 59.9 79.7 61.3 60.6-62.0 64.2 61.9
Gender
Male (N = 804) 12.6% 19.8% 32.6% 35.1% 62.9 61.8-63.9 63.8 60.2
Female (N= 1033) 20.6% 19.4% 31.8% 28.3% 60.0 59.1-61.0 64.7 62.8
Age groups (years)
-54 (N= 625) 19.2% 18.1% 28.0% 34.7% 61.5 60.3-62.8 62.5 63.91
55-64 (N= 476) 17.0% 17.2% 31.5% 34.2% 62.4 60.9-63.8 63.9 61.7
65-74 (N= 428) 13.1% 25.0% 35.1% 26.9% 60.5 59.1-61.9 65.6 61.9
75+ (N = 308) 18.5% 18.5% 37.3% 25.7% 60.0 58.3-61.7 56.6 58.21
Educational level
Low (N= 544) 19.5% 22.1% 36.0% 22.4% 58.42 57.2-59.7 65.03 58.54
Middle (N= 731) 17.7% 18.7% 28.3% 35.3% 62.32 61.1-63.5 62.83 61.84
High (N = 430) 12.8% 18.4% 34.7% 34.2% 62.52 61.1-63.9 65.43 61.64
Self-reported health
Excellent (N = 36) 5.6% 8.3% 25.0% 61.1% 74.2 68.2-80.2 76.3 68.7
Very good (N = 195) 4.1% 9.7% 30.8% 55.4% 71.6 69.4-73.9 66.6 64.3
Good (N = 1010) 12.4% 19.4% 34.8% 33.5% 62.3 61.4-63.2 62.6 59.3
Fair (N = 525) 28.8% 23.2% 29.5% 18.5% 55.8 54.4-57.0 62.5 57.3
Poor (N= 65) 36.9% 27.7% 21.5% 13.9% 52.6 49.4-55.8 57.4 54.3
Only questionnaires with at least 7 items answered were included
1 Extreme age group was 45-54 and 75-84.
2 Education in the Netherlands was divided in three groups; low (no, primary school, or vocational training), middle (secondary or vocational education) or high
(professional higher education or university).
3 Education in Danish analyses was categorised as: unskilled, short (1-3 years) and higher (>3 years).
4 Education in American analyses was categorised as: high school or less, some college and college graduate+.
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Dutch was measured by establishing the test-retest reli-
ability and cross-validation with the scores on the
SBSQ-D, a self report measure of Health literacy. The
test-retest reliability was moderate. As in earlier studies
in the USA [7-9] the association between the PAM and
Health literacy in this study in the Netherlands was weak
to moderate. Given the fact that the SBSQ-D only mea-
sures functional Health literacy, the lack of correlation
in our study is understandable since patient activation is
a broader theoretical concept. Unfortunately, as in the
United States, validated and feasible self report instru-
ments that measure Health literacy in a more compre-
hensive way, including communicative/interactive and
critical skills, are not available in the Netherlands [15].
The Dutch mean PAM score (61.3) is comparable to
the American (61.9) but lower than the Danish (64.2).
This may be due to cultural differences. However, since
Denmark and its social and health care system resembles
the Netherlands more than the United States do, it
would have been likely that contrasts would be most be-
tween the Netherlands and the United States. Though in
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become important themes in the past decade, the United
States have a longer tradition in patient involvement and
focussing on individual responsibilities, also with respect
to health and health care. Since the difference with the
Danish sample is the greatest, sampling differences will
probably play a role as well. Further studies with com-
parable samples (e.g. by age, type of chronic disease) are
necessary to be able to make more substantiated com-
parisons between countries.
Self-reported health is the most distinguishing variable
with respect to the patient activation scores, both in the
Netherlands as in Denmark and the United States. It is
not possible in this cross-sectional study to establish
cause and effect. It is known that people with low activa-
tion scores (level 1 and 2) are more often caught in a cir-
cle of negative emotions and low self esteem [3]. This
might also influence a more negative assessment of their
health status. However, since American studies have
demonstrated that a higher score on the PAM positively
influences various health related behaviours [3,4], one
can expect a positive influence on health by improving
the PAM and by helping professionals to tailor their care
to the specific needs and possibilities of their patients,
which may vary by their activation status. Further stud-
ies in this domain in the Netherlands, using the PAM-13
Dutch, are now beginning.Conclusions
The PAM-13 Dutch is a reliable instrument to measure
patient activation. The level of internal consistency is
good (α= 0.88) and item-rest correlations are moderate
to strong. The test-retest reliability of the instrument
was moderate. Cross-validation with the SBSQ-D, a self
report measure on Health literacy, was weak to moder-
ate. More research is needed into the validity of the Pa-
tient Activation Measure, especially with respect to a
more comprehensive measure of Health literacy.Additional files
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